Zurich-based ADC maker Araris Biotech AG announced the closing of an oversubscribed seed financing round of CHF2.5m with Redalpine, Schroder Adveq and VI Partners contibuting.
Iteos Therapeutics SA, a privately-held biotechnology company developing novel cancer immunotherapies, last week announced the appointment of Matthew Call as its Chief Operating Officer. Matthew will also be responsible for business development.
Although it has only been shown to provide partial protection, the first-ever malaria vaccine is in testing in Africa – and there are many more hopefuls in the pipeline. Will we soon eradicate one of the most deadly pathogens in human history?
https://european-biotechnology.com/wp-content/uploads/2024/04/ebcom_2019_malariasdoom.png5631000Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-08-19 15:13:052024-04-02 16:20:41The Dawn of Malaria’s Doom
The FDA has given the go-ahead to PharmaMar’s proposal to file for accelerated approval its New Drug Application (NDA) for lurbinectedin monotherapy for the treatment of second-line small-cell lung cancer.
Researchers at Karolinska Institutet have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts.
https://european-biotechnology.com/wp-content/uploads/2024/04/Karolinska.jpg10001500Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-08-16 09:35:422019-08-16 09:35:42Swedish researchers find new pain organ
https://european-biotechnology.com/wp-content/uploads/2024/04/Pharming-headquarters.jpg8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-08-13 09:56:012019-08-13 09:56:01Pharming licenses orphan drug from Novartis
https://european-biotechnology.com/wp-content/uploads/2024/04/Zahnstammzellen.jpg10001161Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-08-12 07:42:462019-08-12 07:42:46New stem cell population may help repair teeth
Araris Biotech AG kicks-off with CHF2.5m seed financing
Latest NewsZurich-based ADC maker Araris Biotech AG announced the closing of an oversubscribed seed financing round of CHF2.5m with Redalpine, Schroder Adveq and VI Partners contibuting.
Matthew Call joins Iteos as COO
AppointmentsIteos Therapeutics SA, a privately-held biotechnology company developing novel cancer immunotherapies, last week announced the appointment of Matthew Call as its Chief Operating Officer. Matthew will also be responsible for business development.
The Dawn of Malaria’s Doom
BackgroundAlthough it has only been shown to provide partial protection, the first-ever malaria vaccine is in testing in Africa – and there are many more hopefuls in the pipeline. Will we soon eradicate one of the most deadly pathogens in human history?
PharmaMar moves ahead with NDA for Zepsyre
Latest NewsThe FDA has given the go-ahead to PharmaMar’s proposal to file for accelerated approval its New Drug Application (NDA) for lurbinectedin monotherapy for the treatment of second-line small-cell lung cancer.
Innovative analytical methods for particulate characterization
Sponsored PublicationsManufacturers respond to stricter regulations with novel approaches.
Swedish researchers find new pain organ
Latest NewsResearchers at Karolinska Institutet have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts.
Researchers unravel potential cancer target
Latest NewsBritish researchers have found out what’s going wrong with chromosome segregation in some cancers.
Pharming licenses orphan drug from Novartis
Latest NewsNew stem cell population may help repair teeth
Latest NewsResearchers have discovered that crosstalk of a newly discovered stem cell population with quiescent stem cells may help repair teeth in the future.
Bayer bags iPSC specialist BlueRock Therapeutics
Latest NewsBayer has widened its pipeline in neurology, cardiology, and immunology by acquiring induced pluripotent stem cell specialist BlueRock Therapeutics.